The anti-tumor activity was mainly attributed to local stimulation of lymphokine production (IL-12, IFN-γ, and TNF) resulting in T-cell recruitment, proliferation, and orientation towards a Th1 profile [101,102], as well as non-specific macrophage activation leading to tumor size reduction [103]. The gene discussed is IFNG; the disease is neoplasm.